These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 395674

  • 21. The significance of immunochemically staining calcitonin and CEA in fine-needle aspiration biopsy materials from medullary carcinoma of the thyroid.
    Takeichi N, Ito H, Okamoto H, Matsuyama T, Tahara E, Dohi K.
    Jpn J Surg; 1989 Nov; 19(6):674-8. PubMed ID: 2607690
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
    Henninger S, Schatz H, Stracke H, Wagner U, Kracht J.
    Acta Histochem; 1988 Nov; 83(1):51-6. PubMed ID: 2897752
    [Abstract] [Full Text] [Related]

  • 23. [Value of immunohistochemistry in the study of medullary cancer of the thyroid. Implications of the results for the concept of the APUD system and of apudomas].
    Caillou B, Rougier P, Schlumberger M, Talbot M, Parmentier C.
    Bull Cancer; 1984 Nov; 71(2):140-4. PubMed ID: 6145461
    [Abstract] [Full Text] [Related]

  • 24. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
    Diez JJ, Iglesias P.
    Thyroid; 2004 Nov; 14(11):984-5. PubMed ID: 15678599
    [No Abstract] [Full Text] [Related]

  • 25. Medullary differentiation of anaplastic thyroid carcinoma.
    Nieuwenhuijzen Kruseman AC, Bosman FT, van Bergen Henegouw JC, Cramer-Knijnenburg G, Brutel de la Riviere G.
    Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
    [Abstract] [Full Text] [Related]

  • 26. [Screening for the familial form of medullary cancer of the thyroid].
    Allannic H.
    Bull Cancer; 1984 May; 71(2):125-9. PubMed ID: 6733292
    [Abstract] [Full Text] [Related]

  • 27. [Use of tumor markers in monitoring thyroid carcinoma].
    Gorgone S, Lazzara S, Palmeri R, Belnome N, Calbo L, Dattola P, Melita P.
    Chir Ital; 1987 Feb; 39(1):87-95. PubMed ID: 3607983
    [Abstract] [Full Text] [Related]

  • 28. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
    Carmignani F, Piscopello L, Sammartini C.
    Chir Ital; 1994 Feb; 46(4):42-5. PubMed ID: 7882442
    [Abstract] [Full Text] [Related]

  • 29. An immunohistochemical study in thyroid cancer.
    Beltrami CA, Barbatelli G, Criante P, Paliaga A, Amadi CE.
    Appl Pathol; 1987 Feb; 5(4):229-45. PubMed ID: 2446641
    [Abstract] [Full Text] [Related]

  • 30. Roles of circulating carcinoembryonic antigen and calcitonin in diagnosis of medullary thyroid carcinoma: a comparative study.
    Hamada S, Ishikawa N, Yoshi M, Morita R, Fukunaga M.
    Endocrinol Jpn; 1976 Dec; 23(6):505-10. PubMed ID: 1022524
    [Abstract] [Full Text] [Related]

  • 31. [Tumor markers in medullary thyroid carcinoma. Biochemical and immunohistochemical study].
    López-Guzmán A, Navarro E, Aramendi T.
    An Med Interna; 1996 Jul; 13(7):358-9. PubMed ID: 8962990
    [No Abstract] [Full Text] [Related]

  • 32. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
    Roof BS, Weinstein R, Vujic I, Burdash NM.
    Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
    [Abstract] [Full Text] [Related]

  • 33. [A case of multiple endocrine neoplasia (MEN), type 2A. Immunohistochemical and ultrastructural study of medullary carcinoma of the thyroid].
    Tabuse Y, Tabuse K, Kawaguchi T, Kodama E, Katsumi M, Hiraoka J, Ohno T.
    Nihon Geka Hokan; 1983 Sep 01; 52(5):736-43. PubMed ID: 6144294
    [No Abstract] [Full Text] [Related]

  • 34. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
    Charpin C, Argemi B, Cannoni M, Oliver C, Gillioz P, Vagneur JP, Toga M.
    Ann Pathol; 1984 Sep 01; 4(1):27-35. PubMed ID: 6142718
    [Abstract] [Full Text] [Related]

  • 35. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
    Bojunga J, Dragan C, Schumm-Draeger PM, Usadel KH, Kusterer K.
    Br J Cancer; 2001 Nov 16; 85(10):1546-50. PubMed ID: 11720443
    [Abstract] [Full Text] [Related]

  • 36. [Tumor markers for endocrine neoplasms].
    Okamoto T.
    Gan To Kagaku Ryoho; 2001 Apr 16; 28(4):561-5. PubMed ID: 11329795
    [Abstract] [Full Text] [Related]

  • 37. Localization of a radiolabeled monoclonal antibody to calcitonin in rat medullary thyroid carcinoma allografts.
    Samaan NA, Yang KP.
    Henry Ford Hosp Med J; 1987 Apr 16; 35(2-3):153-6. PubMed ID: 3692888
    [No Abstract] [Full Text] [Related]

  • 38. [A giant struma histologically confirmed as a medullary carcinoma with multiple systemic bone metastasis].
    Saito M, Karaki Y, Kasagi T, Kushibuchi T, Tajika S, Tazawa K, Fujimaki M.
    Gan No Rinsho; 1990 Dec 16; 36(15):2569-74. PubMed ID: 2266589
    [Abstract] [Full Text] [Related]

  • 39. [Radioimmunological determination of calcitonin in monitoring medullary carcinoma of the thyroid].
    Trucchi M, Marchisio M, Roncallo F, Schenone F, Santaniello B.
    Arch Maragliano Patol Clin; 1980 Dec 16; 36():25-30. PubMed ID: 6896418
    [No Abstract] [Full Text] [Related]

  • 40. Endocrine aspects of medullary thyroid carcinoma.
    Raue F.
    Recent Results Cancer Res; 1990 Dec 16; 118():64-9. PubMed ID: 1978382
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.